Even as countries across the world are trying to develop a vaccine against Coronavirus, the Indian government has decided to use to go the traditional way. The Indian government is working on four ayurvedic medicine formulations to treat COVID-19. The AYUSH ministry announced on Thursday that the trials are likely to begin within a week.
Union Minister of State for AYUSH Shripad Y Naik took to Twitter and wrote, “The @moayush & the @CSIR_IND are working together on validating four Ayush formulations against #COVID19Pandemic and the trials will start within one week. These formulations will be tried as an add-on therapy and standard care for COVID-19 patients.”
THE FOUR TRIALS
The AYUSH Ministry will be adopting four interventions, namely- Ashwagandha, Yashtimadhu (Mulethi), Guduchi +Pippali (Giloy) and a poly herbal formulation.
Naik said that he is “sure and quite hopeful” that the Ayurveda will pave “way to overcome this pandemic”.
Notably, Prime Minister Narendra Modi on Tuesday had pitched for India’s indigenous businesses.
Meanwhile, the US FDA has given the go ahead to Gilead’s antiviral drug Remdesivir for emergency use on COVID-19 patients.